In the News

OHSU spinout NeuraMedica raises $1M
March 2, 2021
Founded in 2014, NeuroMedica's first grant was from OHSU's Oregon Clinical and Translational Research Institute (OCTRI). Read more.

OHSU Startup ServerDome could be the future of small data centers
February 17, 2021
Shape matters: Why this dome could be the future of small data centers.

Business Oregon announced the release of Oregon’s 10-Year Innovation Plan
February 16, 2021
Futures Commission Releases 10-Year Innovation Plan to Support Oregon's Economy by Investing in Innovation. 

OHSU, Ionis Pharmaceuticals to develop drugs for ‘undruggable’ cancer targets
January 27, 2021
OHSU announced the formation of a collaboration with Ionis Pharmaceuticals designed to discover and develop novel therapeutics in the area of hematologic malignancies, or cancers of the blood.

Study suggests compound protects myelin, nerve fibers
January 13, 2021
Recent research on a compound developed at OHSU and licensed into OHSU startup company Autobahn Therapeutics, shows protection of the myelin and nerve fibers, demonstrating great promise in treating and preventing the progression of multiple sclerosis and other neurodegenerative diseases.

Vir Biotechnology initiates phase I clinical trial
January 6, 2021
OHSU startup, Vir Biotechnology, initiates phase I clinical trial of a vaccine vector platform originally conceived and developed at OHSU. Read more.

2021 Biomedical Innovation Program to fund 4 OHSU projects
December 17, 2020

OHSU physician honored for co-invention of eye-imaging technology
December 4, 2020
Prolific OHSU inventor David Huang, M.D., Ph.D. was awarded a Visionary Prize from the Sanford and Susan Greenberg Prize to End Blindness during the live-streamed event on December 14th.  

OHSU startup Autobahn to Initiate Clinical Development for ABX-002
December 1, 2020
Autobahn Therapeutics recently announced that it has successfully completed a pre-IND meeting with the U.S. FDA regarding the development plan for its lead candidate, ABX-002, a potent and selective thyroid hormone receptor beta agonist.  

OHSU Startup, NOUS Imaging, Receives 510(k) Clearance
September 21, 2020
OHSU Startup NOUS Imaging, a medical imaging software company, received 510(k) clearance from FDA for FIRMM Software.

CTIP Accelerator Announces 2020 Winners for Catalyzing Pediatric Innovation Annual Grant Competition
September 4, 2020
Promedix, a company being formed based on OHSU technology developing novel devices and technologies for pediatric patients was one of five innovators selected as winners for CTIP’s fourth Catalyzing Pediatric Grant (CPI) competition.

Innovosource releases the 2020 Mind the Gap Report
July 14, 2020
The Mind the Gap Report supports the development of and partnership with university translational research, proof of concept, startup, and venture gap fund and accelerator programs. The Report provides an analysis of the early-stage funding landscape.

OHSU establishes remote emergency response critical care network as part of Army-funded project
July 7, 2020
Oregon Health & Science University is establishing an emergency critical care network that could prove indispensable if Oregon experiences a secondary surge or ongoing waves of COVID-19 cases. 

2020 OHSU Research and Innovation Awards
June 16, 2020
OHSU Technology Transfer and OHSU Collaborations and Entrepreneurship recognizes innovation, entrepreneurship, industry partnership and technology commercialization.

Autobahn Therapeutics Takes Aim at CNS Disorders with $76 Million Series B
Jun. 9, 2020
The company’s work is built on research conducted by Thomas Scanlan, a professor of Chemical Physiology and Biochemistry at Oregon Health & Science University.

Vir Biotechnology Initiates Phase 1 Clinical Trial of VIR-3434 for Chronic Hepatitis B Virus Infection
May 27, 2020

Fitbit plans to make emergency ventilators for Covid-19
May 15, 2020
David Sheridan, an assistant professor of emergency medicine at OHSU, said he and several of his colleagues helped provide feedback to Fitbit about the core components that the ventilators would need.

“Engineering Rounds” at Oregon Health & Science University, made possible by industry partnership
May 11, 2020
Welch Allyn (later acquired by Hillrom), a medical device company, joined forces with Oregon Health & Science University (OHSU) to develop a new clinical immersion platform called “Engineering Rounds,” which allowed medical equipment design engineers and product developers the chance to engage with clinicians and patients.

Key to Oregon Study on COVID-19
May 1, 2020
OHSU, the state of Oregon and the OHSU-PSU School of Public Health will conduct a statewide COVID-19 research study to inform the approach for reopening Oregon.

OHSU agrees to relax licensing agreements to speed COVID treatments
Apr. 17, 2020 - Portland Business Journal
Oregon Health & Science University has joined with other research universities to relax traditional licensing rules, with a goal of expediting promising treatments, vaccines and diagnostic tools for COVID-19. Read more.

OHSU expedites promising new technologies to tackle COVID-19
Apr. 16, 2020
Oregon Health & Science University is joining other universities and academic health centers across the country to relax traditional licensing agreements with the goal of expediting the development of promising technologies to diagnose, treat and prevent COVID-19.

Archived News